SCHEDULE 13G/A: Deerfield Management Group Maintains Significant Stake in Nuvalent, Inc. with 27.59% Beneficial Ownership

An amendment to a Schedule 13G filing reveals that Deerfield Management Company, L.P. and its affiliated entities collectively hold a 27.59% beneficial ownership stake in Nuvalent, Inc.'s Class A common stock as of December 31, 2024.

Summary

• Deerfield Management Company, L.P. and James E. Flynn, along with their affiliated funds, collectively beneficially own 23,582,278 shares of Nuvalent, Inc.'s Class A common stock.
• This aggregate ownership represents 27.59% of the total outstanding Class A common stock of Nuvalent, Inc.
• The beneficial ownership includes 17,991,024 shares of Class A common stock directly held by Deerfield Partners, L.P., Deerfield Private Design Fund IV, L.P., and Deerfield Healthcare Innovations Fund, L.P.
• Additionally, 5,435,254 shares of Class A common stock are issuable upon conversion of an equal number of Class B common stock held by Deerfield Private Design Fund IV, L.P. and Deerfield Healthcare Innovations Fund, L.P.
• An additional 156,000 shares of Class A common stock are issuable upon the exercise of options held by Cam Wheeler and Joe Pearlberg, employees of Deerfield Management Company, L.P., exercisable within sixty days.
• The terms of the Class B common stock include an 'Ownership Cap' which restricts conversion if it would result in beneficial ownership exceeding 4.9% of the total Class A common stock outstanding.
• The filing is an Amendment No. 5 to a Schedule 13G, indicating an update to previously reported beneficial ownership.
• The reporting persons are a group, including various Deerfield entities and James E. Flynn, all based in Delaware or the United States, with their principal business office in New York, NY.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that inherently indicates positive or negative sentiment regarding the company's performance or outlook. It is a neutral regulatory update.

Positives

• The continued significant beneficial ownership by Deerfield Management, a specialized healthcare investment firm, may signal confidence in Nuvalent, Inc.'s long-term prospects.
• The substantial stake held by a prominent institutional investor provides a degree of stability to the shareholder base.

Negatives

• The 'Ownership Cap' on Class B common stock conversion limits the immediate ability of the holders to convert these shares into Class A common stock if it would exceed 4.9% of the outstanding Class A shares, potentially restricting their immediate voting power or liquidity for those specific shares.

Risks

• The 'Ownership Cap' on Class B common stock conversion means that a significant portion of the reported beneficial ownership (5,435,254 shares) cannot be fully converted into Class A common stock if it would cause the holder's beneficial ownership to exceed 4.9% of the total Class A common stock outstanding. This limits the immediate influence and liquidity of these specific shares.

Future Outlook

NA

Industry Context

Deerfield Management Company is a prominent investment firm specializing in the healthcare sector. Their significant and continued stake in Nuvalent, Inc., a biotechnology company, aligns with their strategic focus on innovative healthcare companies. This filing reflects a standard disclosure for large institutional investors in the biotech industry.

Corporate Governance

Related Party Transactions

• The various Deerfield entities (Deerfield Management Company, L.P., Deerfield Mgmt IV, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Healthcare Innovations Fund, L.P., Deerfield Mgmt, L.P., Deerfield Partners, L.P.) and James E. Flynn are deemed to constitute a group for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934 due to their relationships, indicating a coordinated investment approach.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake in the company, which can influence market perception and investor confidence.
• Company Management: Awareness of a large, coordinated shareholder group may influence strategic decisions and corporate governance considerations.

Key Dates

Keywords

Nuvalent Inc., Deerfield Management Company, Schedule 13G/A, Beneficial Ownership, Class A Common Stock, Class B Common Stock, Institutional Investor, Healthcare Investment, SEC Filing, Shareholder Stake